Tectonic Therapeutic Announces Participation at Investor Conferences in March Feb 27, 2024 07:00AM
AVROBIO Inc. (AVRO) and Tectonic Therapeutic Announce Merger Jan 30, 2024 08:00AM
AVROBIO and Tectonic Therapeutic Announce Merger Jan 30, 2024 08:00AM
AVROBIO (AVRO) Sells Cystinosis Gene Therapy Program for $87.5M Jun 12, 2023 07:01AM
AVROBIO Completes Sale of Cystinosis Gene Therapy Program for $87.5 Million Jun 12, 2023 07:00AM


May 22, 2023 07:00AM AVROBIO Inc. (AVRO) to Sell Cystinosis Gene Therapy Program for $87.5M
May 22, 2023 07:00AM AVROBIO Announces Agreement to Sell Cystinosis Gene Therapy Program for $87.5 Million
Mar 3, 2023 07:00AM AVROBIO to Participate in Cowen’s 43rd Annual Health Care Conference
Feb 8, 2023 12:42PM AVROBIO (AVRO) exploring potential sale after Novartis interest - source
Mar 1, 2022 07:00AM AVROBIO to Present at Two Upcoming Investor Conferences in March
Jan 28, 2022 07:00AM AVROBIO to Present at Cowen’s 2nd Annual Genetic Medicines Summit
Feb 25, 2021 07:00AM AVROBIO to Present at Three Upcoming Investor Conferences in March
Jan 22, 2021 07:00AM AVROBIO to Present at the Cowen 2021 Gene Therapy: CMC & Regulatory Summit
Nov 24, 2020 04:19PM AVROBIO Announces Closing of Underwritten Public Offering
Nov 20, 2020 05:59AM AVROBIO Inc. (AVRO) Prices 5M Share Common Offering at $15/Sh
Nov 19, 2020 10:06PM AVROBIO Announces Pricing of Underwritten Public Offering of $75 Million of Common Stock
Nov 19, 2020 04:10PM AVROBIO Inc. (AVRO) Announces $75M Proposed Public Offering of Common Stock
Nov 19, 2020 04:09PM AVROBIO Announces Proposed Public Offering of Common Stock
Feb 24, 2020 07:00AM AVROBIO to Present at the Cowen and Company 40th Annual Health Care Conference
Feb 18, 2020 04:01PM AVROBIO Announces Closing of Underwritten Public Offering
Feb 13, 2020 05:47AM AVROBIO, Inc (AVRO) Prices 4.35M Share Common Offering at $23/Sh
Feb 12, 2020 10:08PM AVROBIO Announces Pricing of Underwritten Public Offering of $100 Million of Common Stock
Feb 12, 2020 04:04PM AVROBIO, Inc (AVRO) Announces Proposed $100M Public Offering of Common Stock
Feb 12, 2020 04:01PM AVROBIO Announces Proposed Public Offering of Common Stock
Jul 19, 2019 04:01PM AVROBIO Announces Closing of Underwritten Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
Jul 17, 2019 05:41AM AVROBIO, Inc (AVRO) Prices 6.5M Share Common Offering at $18.50/Sh
Jul 16, 2019 09:58PM AVROBIO Announces Pricing of Underwritten Public Offering of $120.25 Million of Common Stock
Jul 16, 2019 04:01PM AVROBIO, Inc (AVRO) Announces Proposed $100M Public Offering of Common Stock
Jul 16, 2019 04:01PM AVROBIO Announces Proposed Public Offering of Common Stock
Mar 5, 2019 07:00AM AVROBIO, Inc. to Present at the Cowen and Company 39th Annual Health Care Conference
Jul 16, 2018 05:37AM Cowen Starts Avrobio Inc. (AVRO) at Outperform
Jun 25, 2018 04:30PM AVROBIO, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option
Jun 25, 2018 04:30PM AVROBIO, Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Overallotment Option
Jun 22, 2018 09:22AM UPDATE: AVROBIO, Inc. (AVRO) IPO Opens 54% Higher
Jun 22, 2018 09:21AM UPDATE: AVROBIO, Inc (AVRO) Prices 5.25M Share IPO at $19/Sh
Jun 20, 2018 08:42PM AVROBIO, Inc. Announces Pricing of Initial Public Offering